0.00
price down icon100.00%   -7.04
after-market Dopo l'orario di chiusura: 7.29 7.29 +
loading

180 Life Sciences Corp Azioni (ATNF) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
27.08%
1.7304
2.373 1.4064 0.9791 1.8467
Operating Income/Loss
27.08%
-1.7304
-2.373 -1.4064 -0.9791 -1.8467
Nonoperating Income/Loss
2.01%
0.00381
0.00374 -3.1631 0.1424 1.8585
Income/Loss From Continuing Operations Before Tax
27.12%
-1.7266
-2.3692 -4.5695 -0.8367 0.0118
Income/Loss From Continuing Operations After Tax
27.12%
-1.7266
-2.3692 -4.2735 -0.8367 0.0118
Net Income/Loss
27.12%
-1.7266
-2.3692 -4.2735 -0.8367 0.0118
Preferred Stock Dividends And Other Adjustments
-
- 8.0115 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
61.28%
5.7081
3.5393 0.0688 0.9806 0.9191
Diluted Average Shares
61.28%
5.7081
3.5393 0.0688 0.9806 0.9191
Basic Earnings Per Share
55.22%
-0.30
-0.67 -13.25 -0.85 0.01
Diluted Earnings Per Share
55.22%
-0.30
-0.67 -13.25 -0.85 0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 8.0115 - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):